Great Lakes Advisors LLC Buys Shares of 28,963 Harrow, Inc. (NASDAQ:HROW)

Great Lakes Advisors LLC bought a new stake in Harrow, Inc. (NASDAQ:HROW) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 28,963 shares of the company’s stock, valued at approximately $972,000. Great Lakes Advisors LLC owned 0.08% of Harrow as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. State Street Corp raised its position in Harrow by 2.2% in the third quarter. State Street Corp now owns 730,973 shares of the company’s stock valued at $32,865,000 after purchasing an additional 15,554 shares during the period. Geode Capital Management LLC raised its holdings in shares of Harrow by 0.6% in the 3rd quarter. Geode Capital Management LLC now owns 722,730 shares of the company’s stock valued at $32,500,000 after buying an additional 3,960 shares during the period. Braidwell LP raised its holdings in shares of Harrow by 47.9% in the 3rd quarter. Braidwell LP now owns 439,638 shares of the company’s stock valued at $19,766,000 after buying an additional 142,450 shares during the period. First Turn Management LLC purchased a new stake in shares of Harrow in the 3rd quarter valued at $14,683,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Harrow by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 255,218 shares of the company’s stock valued at $8,563,000 after buying an additional 3,589 shares during the period. Hedge funds and other institutional investors own 72.76% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HROW shares. HC Wainwright started coverage on Harrow in a report on Thursday, February 6th. They issued a “buy” rating and a $57.00 price objective on the stock. B. Riley cut their price objective on Harrow from $73.00 to $69.00 and set a “buy” rating on the stock in a report on Wednesday, December 4th.

Harrow Trading Up 3.5 %

HROW opened at $23.01 on Friday. Harrow, Inc. has a 12 month low of $9.30 and a 12 month high of $59.23. The stock has a market capitalization of $819.50 million, a price-to-earnings ratio of -24.48 and a beta of 0.69. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44. The business has a fifty day moving average price of $30.45 and a 200 day moving average price of $38.85.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.